Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?

This pharma company is posting double-digit revenue growth.The stocks that led gains in the S&P 500 Index in the first half primarily were in the field of tech, operating in the high-growth area of artificial intelligence (AI). But an exception emerged, and this company operates in the generally slower-but-steady growth business of pharmaceuticals. I'm talking about Eli Lilly (LLY 0.38%). The pharma giant's shares soared 55% in the first half as the company posted double-digit revenue growth -- and amid exc ...